VitroGel® hydrogels
VitroGel® hydrogels from TheWell Bioscience closely mimic the natural extraceullar matrix (ECM) environment and give an outstanding balance of biological functions and operating ease to establish a robust 3D cell culture platform. Our cutting-edge hydrogels enable high-throughput processing and scale-up of the 3D cell platform for multiple applications, from organoids to stem cells to invasion assay, angiogenesis assay, and more.
Flagship products of TheWell Bioscience
VitroGel Hydrogel Matrix
ready-to use, xeno-free (animal origin-free) functional hydrogel system
VitroGel ORGANOID
ready-to use, xeno-free (animal origin-free) hydrogel system for organoid culture
VitroGel 3D High Concentration
tunable, xeno-free hydrogel, high concentration (3mL kit)
Full control of growth factors with VitroGel system
With the xeno-free and growth factor-free VitroGel ORGANOID system, researchers can now have full control of the growth factors for enriching the hydrogel system for organoid formation.
Dome Culture Method – Now Available
Many researchers wonder if they can use the traditional organoid dome culture method when using our xeon-free VitroGel system. We found a simple transition method to adapt the dome culture method with the VitroGel system by simply using the non-tissue culture treated plate.
5 Different Culture Protocols Available
We are excited to share the latest culture protocols with you, covering the below 5 different culture methods:
- 3D Dome Method with VitroGel system
- 2D Dome Method with VitroGel system
- 2D Hydrogel Coating with VitroGel system
- 3D Cell Culture Encapsulation with VitroGel system
- Hydrogel-Cell Droplet: A unique method for VitroGel ORGANOID products only
- TheWell Bioscience, ‘Protocol: Vitrogel Organoids’, Available at https://cdn.thewellbio.com/wp-content/uploads/2020/11/Protocol_VitroGel-Organoid.pdf
LAB-A-PORTER: Your ultimate research partner
Starting in 2018, LAB-A-PORTER strives to source and channel a variety of research products globally, covering tools on genomic and proteomic research, stem cell and organoid research, in-vivo research, tools on CRISPR technology and next-generation sequencing. Through LAB-A-PORTER, researchers could gain access to their desired products from worldwide renowned manufacturers at their fingertips. Contact us today to learn more about our breadth of product offerings for your next research projects!
Featured brands
Xeno-free hydrogel
Our xeno-free hydrogel system (VitroGel®) can closely mimic the natural extracellular matrix and open the door to clinical applications for 3D organoid models. Cells from different sources such as patient-derived cells can be cultured with our system with full lab automation potential for personalized 3D cell models, including highly complicated organoid models and co-culture systems.
Recombinant proteins
PeproTech creates the building blocks of your life science research by manufacturing high-quality products that advance scientific discovery and human health. Since 1988, we have grown into a global enterprise with state-of-the-art manufacturing facilities in the US, and offices around the world.
With over 2,000 products, PeproTech has developed and refined innovative protocols to ensure quality, reliability, and consistency.
Recombinant proteins
Recombinant proteins
OriGene, a global research tool company, offers a range of research tools for genome and proteome analysis which include cDNA clones, antibodies, recombinant proteins and custom services.
OriGene offers these essentials for all genes for human and mouse. OriGene has a searchable bank of over 586,116 cDNA Clones, many of them are sequenced and protein expression is verified. In addition, we offer over 27K recombinant proteins and 144K primary antibodies. We are only company to provide complete solution starting from clone to antibody and assays, a one-stop-shop leading you from genomics to proteomics.
Small molecules
CRISPR technologies
Synthego is a genome engineering company that enables the acceleration of life science research and development in the pursuit of improved human health.
The company leverages machine learning, automation, and gene editing to build platforms for science at scale. With its foundations in engineering disciplines, the company’s platform technologies vertically integrate proprietary hardware, software, bioinformatics, chemistries, and molecular biology to advance basic research, target validation, and clinical trials.
Read more